• CLSI M23A2

CLSI M23A2

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2

Clinical and Laboratory Standards Institute, 05/01/2001

Publisher: CLSI

File Format: PDF

$109.00$219.97


Published:01/05/2001

Pages:28

CLSI M23A2 addresses the required and recommended data needed for the selection of appropriate interpretive standards and quality control guidelines for antimicrobial agents.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.

More CLSI standard pdf

CLSI QMS03-A4

CLSI QMS03-A4

Training and Competence Assessment; Approved Guideline--Fourth Edition; QMS03Ed4E

$90.00 $180.00

CLSI QMS21 (R2021)

CLSI QMS21 (R2021)

Purchasing and Inventory Management, 1st Edition, QMS21Ed1E

$90.00 $180.00

CLSI I/LA20

CLSI I/LA20

Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E Antibodies of Defined Allergen Specificities, 3rd Edition, ILA20Ed3E

$90.00 $180.00

CLSI QMS24 (R2021)

CLSI QMS24 (R2021)

Using Proficiency Testing and Alternative Assessment to Improve Medical Laboratory Quality, QMS24Ed3E

$90.00 $180.00